| A Study of Blood-stage Controlled Human Plasmodium Falciparum Malaria Infection in Tanzania (NCT04788862) | University of Oxford | 2022-07-18 |
| Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in South Sudan (NCT05471544) | Malaria Consortium | 2022-07-18 |
| Chemoprevention Efficacy Study in Burkina Faso (NCT05478954) | Malaria Consortium | 2022-07-15 |
| Evaluating the Clinical Performance and Usability of Novel Malaria RDTs in Brazil (NCT05317117) | PATH | 2022-07-04 |
| Health Education by Buddhist Monks to Promote Malaria Knowledge and Preventive Practices in Rural Myanmar (NCT06386367) | Myanmar Health Network Organization | 2022-07-01 |
| Abbott NxTekTM Malaria RDT WHO Prequalification Study (NCT05444790) | Foundation for Innovative New Diagnostics, Switzerland | 2022-06-30 |
| Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children (NCT05354258) | London School of Hygiene and Tropical Medicine | 2022-06-16 |
| Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants (NCT05285735) | Amivas Inc. | 2022-06-08 |
| Permethrin-treated Baby-wraps for the Prevention of Malaria in Children (NCT05391230) | University of North Carolina, Chapel Hill | 2022-06-03 |
| Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda (NCT05323721) | Malaria Consortium | 2022-06-01 |
| Performance Evaluation of Malaria Plus Rapid Diagnostic Tests (RDTs) for the Detection of Plasmodium Infections in Patients With Symptoms Suggestive of Malaria (NCT05286359) | Abbott Rapid Dx | 2022-05-24 |
| Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines (NCT05155579) | University of Oxford | 2022-05-14 |
| Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria (NCT03503058) | Sanaria Inc. | 2022-05-07 |
| Plasmodium Vivax Among Duffy Negative Population in Cameroon. (NCT05058885) | University of Dschang | 2022-05-02 |
| ERASE - Impact of COVID-19 on Malaria Control (NCT05348746) | Doctors with Africa - CUAMM | 2022-05-01 |
| Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Efavirenz (NCT05330273) | Novartis Pharmaceuticals | 2022-04-28 |
| Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Cameroon (NCT05340153) | University of Yaounde 1 | 2022-04-11 |
| PfSPZ Vaccine Trial in Malian Children (NCT04940130) | Sanaria Inc. | 2022-04-01 |
| MMV533 Plasmodium Falciparum Volunteer Infection Study (NCT05205941) | Medicines for Malaria Venture | 2022-03-30 |
| Anti-malaria MAb in Malian Children (NCT05304611) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-03-18 |
| Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) (NCT04966702) | Barcelona Institute for Global Health | 2022-03-17 |
| In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambique (NCT05343312) | Centro de Investigacao em Saude de Manhica | 2022-03-16 |
| Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir (NCT05236530) | Novartis Pharmaceuticals | 2022-03-09 |
| Evaluating ATSBs for Malaria Reduction in Kenya (NCT05219565) | Liverpool School of Tropical Medicine | 2022-03-07 |
| Community Dynamics of Malaria Transmission in Humans and Mosquitoes at Maferinyah Sub-Prefecture, Guinea (NCT04969913) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-03-07 |
| Blood-Stage Plasmodium Vivax Cell Bank (NCT05095272) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-02-15 |
| MULTIple Doses of IPTi Proposal: a Lifesaving High Yield Intervention (NCT05085340) | Barcelona Institute for Global Health | 2022-02-14 |
| Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP) (NCT04978272) | Grant Dorsey, M.D, Ph.D. | 2022-02-08 |
| Star Homes Project 2 (NCT04529434) | University of Oxford | 2022-01-04 |
| Malaria Control : Improving Access to Prevention, Diagnostic and Care for Vulnerable Rural Communities (NCT05535465) | Institut de Recherche pour le Developpement | 2021-12-01 |
| RapiGEN BIOCREDIT Malaria Ag RDTs WHO Prequalification Study (NCT05085301) | Foundation for Innovative New Diagnostics, Switzerland | 2021-12-01 |
| Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Itraconazole (NCT05084651) | Novartis Pharmaceuticals | 2021-11-18 |
| Monitoring Pregnant Women for Antimalarial Drug Resistance (NCT05072613) | University of Oxford | 2021-11-11 |
| Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine (NCT05041556) | Kintampo Health Research Centre, Ghana | 2021-10-18 |
| Plasmodium Falciparum Genomic Intelligence in Mozambique (NCT05306067) | Centro de Investigacao em Saude de Manhica | 2021-10-12 |
| Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia (NCT04704674) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-09-30 |
| Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults (NCT04966871) | Sanaria Inc. | 2021-09-27 |
| Trial to Evaluate L9LS in Healthy Adults (NCT05019729) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-09-13 |
| A Study Of Zy-19489 Administered Via Oral Route To Investigate The Safety, Tolerability And Pharmacokinetics In Healthy Adult Human Subjects (NCT05206201) | Zydus Lifesciences Limited | 2021-08-25 |
| Baromètre Santé Adulte 2021-2022 (NCT05218304) | Agence Sanitaire et Sociale de Nouvelle Calédonie | 2021-07-26 |
| Spatial Repellents for Vector Control (NCT04795648) | University of Notre Dame | 2021-07-08 |
| Boosting the Impact of SMC Through Simultaneous Screening and Treatment of Roommates (NCT04816461) | Institut de Recherche en Sciences de la Sante, Burkina Faso | 2021-07-07 |
| Impact of Malaria Mass Drug Administration on Malaria Prevalence in Under 15 Children and Pregnant Women (NCT07358767) | Noguchi Memorial Institute for Medical Research | 2021-07-01 |
| Molecular Basis of Erythrocyte Invasion by Plasmodium Vivax Into Duffy-Negative Erythrocytes in Mali (NCT03304691) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-06-30 |
| Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities (NCT04864444) | University of California, San Francisco | 2021-06-19 |
| LAMP Detection of Malaria in PREGnancy (LAMPREG) Trial (NCT03754322) | University of Calgary | 2021-06-18 |
| Malaria Transmission in Humans and Mosquitoes at the Area of Sabou, Burkina Faso (NCT04650815) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-06-10 |
| Safety and Efficacy of Maytenus Senegalensis for the Treatment of Uncomplicated Malaria (NCT04944966) | Ifakara Health Institute | 2021-06-02 |
| Evaluation of Three Artemisinin-based Combinations for the Treatment of Uncomplicated Malaria in Childreen in Burkina Faso (CHIMIO2) (NCT04778813) | Centre national de recherche et de formation sur le paludisme | 2021-06-01 |
| Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal (NCT05050825) | Foundation for Innovative New Diagnostics, Switzerland | 2021-05-03 |
| Evaluation of IR3535 as a Spatial Repellent for Malaria Control. (NCT04419766) | Universidade Nova de Lisboa | 2021-04-28 |
| Proactive Community Case Management for Malaria in Zambia (NCT04839900) | PATH | 2021-04-15 |
| Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia (NCT04844099) | Liverpool School of Tropical Medicine | 2021-04-09 |
| Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: TESTsmART Aim 2 - Nigeria (NCT04428385) | Duke University | 2021-03-15 |
| Clinical Investigation Study to Evaluate the Consistency and Reproducibility of Two Consecutive Mosquito Feeding Assays (NCT04666350) | PATH | 2021-03-09 |
| Spatial Repellents for the Prevention of Malaria in Kenya (NCT04766879) | University of Notre Dame | 2021-03-02 |
| Safety and Efficacy of CIS43LS Anti-malaria mAb in Mali (NCT04329104) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-02-15 |
| Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria (NCT04672577) | Patricia Schlagenhauf | 2021-01-30 |
| Uganda Housing Modification Study (NCT04622241) | Infectious Diseases Research Collaboration, Uganda | 2021-01-29 |
| Household-level Impact of IPT of Malaria in Schoolchildren (NCT04660110) | Makerere University | 2021-01-28 |
| Characterizing Humoral Immune Response to Mosquito Bites (NCT04478370) | University of Oxford | 2021-01-21 |
| Optimizing Malaria Treatment for HIV-Malaria Co-infected Individuals (NCT04708496) | Makerere University | 2021-01-18 |
| Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC (NCT04235361) | University of Stirling | 2021-01-15 |
| Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: TESTsmART Aim 2 - Kenya (NCT04428307) | Duke University | 2021-01-11 |
| Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso (NCT04695197) | Liverpool School of Tropical Medicine | 2021-01-08 |
| An MRI Ancillary Study of a Malaria Fever Investigation (NCT05746819) | University of Rochester | 2021-01-02 |
| Effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) Model in Myanmar (NCT04695886) | Macfarlane Burnet Institute for Medical Research and Public Health Ltd | 2021-01-01 |
| Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda (NCT04336189) | Grant Dorsey, M.D, Ph.D. | 2020-12-28 |
| Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Mozambique (NCT04724161) | PATH | 2020-12-09 |
| Attractive Targeted Sugar Bait Phase III Trial in Zambia (NCT04800055) | PATH | 2020-12-01 |
| Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo (NCT04618523) | Ministry of Public Health, Democratic Republic of the Congo | 2020-10-26 |
| LLIN Evaluation in Uganda Project (NCT04566510) | University of California, San Francisco | 2020-10-17 |
| Innovation Platform (NCT04558528) | Foundation for Innovative New Diagnostics, Switzerland | 2020-10-01 |
| Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso (NCT04545905) | PATH | 2020-09-22 |
| Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Ruxolitinib With Artemether-lumefantrine (NCT04456634) | Medicines for Malaria Venture | 2020-09-10 |
| Baseline Cohort Malaria Morbidity Study (NCT04601714) | Groupe de Recherche Action en Sante | 2020-09-07 |
| Perceptions, Representations and Experiences of Malaria Prophylaxis in Patients Born in Endemic Areas and Living in France. (NCT04494854) | Centre Hospitalier Intercommunal Creteil | 2020-09-01 |
| Efficacy of Antimalarial Drugs Used for the Treatment of Uncomplicated Malaria, Plasmodium Falciparum, at the Agadez, Gaya and Tessaoua Sentinel Sites (NCT05070520) | Programme National de Lutte contre le Paludisme, Niger | 2020-09-01 |
| Gut and Azithromycin Mechanisms in Infants and Children II (NCT04315272) | University of California, San Francisco | 2020-08-21 |
| Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Mozambique (NCT04716387) | PATH | 2020-08-18 |
| A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of a Single Doses of MMV533. (NCT04323306) | Medicines for Malaria Venture | 2020-08-12 |
| Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects (NCT04321252) | Novartis Pharmaceuticals | 2020-07-22 |
| Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania (NCT04245033) | National Institute for Medical Research, Tanzania | 2020-07-20 |
| Assessment of a Combined Strategy of SMC + Nutrients Supplementation to Tackle Malaria and Malnutrition (NCT04238845) | Institut de Recherche en Sciences de la Sante, Burkina Faso | 2020-07-13 |
| Malaria Prevalence Around Maferinyah, Guinea (NCT04105855) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-07-13 |
| Dihydroartemisinin-piperaquine for Seasonal Malaria Chemoprophylaxis in Tanzania (NCT05874869) | Richard Mwaiswelo | 2020-07-01 |
| Efficacy of Two Dual Active Ingredient Long Lasting Insecticidal Nets for Control of Malaria Transmitted by Pyrethroid Resistant Vectors in Benin (NCT03931473) | London School of Hygiene and Tropical Medicine | 2020-06-01 |
| Study to Assess Efficacy of Artemether-lumefantrine Prophylaxis Against Forest Malaria in Cambodia (PAL_Cambodia) (NCT04041973) | University of Oxford | 2020-03-11 |
| Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Rwanda (NCT04230161) | PATH | 2020-02-24 |
| Automated Microscopy Evaluation Study (NCT04558515) | Foundation for Innovative New Diagnostics, Switzerland | 2020-02-01 |
| Trial to Evaluate CIS43LS in Healthy Adults (NCT04206332) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-01-07 |
| Biomarkers of P. Vivax Relapse (NCT04228315) | Armed Forces Research Institute of Medical Sciences, Thailand | 2019-11-19 |
| Assessing the Impact of Group Antenatal Care on IPTp Uptake in Tanzania (NCT04148690) | Centers for Disease Control and Prevention | 2019-11-15 |
| Malaria High-Risk Populations in Namibia (NCT04094727) | University of California, San Francisco | 2019-10-31 |
| Getting Malaria "Off the Back" of Women and Children in Western Uganda (NCT04102592) | University of North Carolina, Chapel Hill | 2019-10-28 |
| Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants (NCT03937817) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-09-25 |
| Improving Maternal heAlth by Reducing Malaria in African HIV Women (NCT03671109) | Barcelona Institute for Global Health | 2019-09-18 |
| A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria (NCT04020653) | Neopharma Japan Co., Ltd. | 2019-09-06 |
| Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas (NCT03897673) | University of Minnesota | 2019-09-01 |
| Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas (NCT03916003) | Menzies School of Health Research | 2019-08-18 |